Reduced predictability in regulatory decision-making can prompt pharmaceutical and biotechnology companies to move investment dollars elsewhere.
November 04, 2025
high
general
Describes how industry investment decisions are influenced by the perceived predictability of regulatory agencies such as the FDA.
Pharmaceutical companies commonly argue that government price controls on drugs could reduce incentives or resources for pharmaceutical research and development.
October 11, 2025
high
claim
This is a frequently cited industry position in debates over drug-price regulation.